Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects

[1]  H. Jara,et al.  Global and Regional Brain Assessment with Quantitative MR Imaging in Patients with Prior Exposure to Linear Gadolinium-based Contrast Agents. , 2017, Radiology.

[2]  Helena Antić,et al.  Myocardial tissue characterization by magnetic resonance imaging , 2017 .

[3]  Sebastian Kozerke,et al.  Analysis of spatiotemporal fidelity in quantitative 3D first-pass perfusion cardiovascular magnetic resonance , 2017, Journal of Cardiovascular Magnetic Resonance.

[4]  S. Piechnik,et al.  Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance , 2017, Journal of Cardiovascular Magnetic Resonance.

[5]  Kyunghwa Han,et al.  Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model , 2017, European Radiology.

[6]  H. Bezerra,et al.  T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation. , 2016, European heart journal cardiovascular Imaging.

[7]  M. Robson,et al.  Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction. , 2016, Journal of the American College of Cardiology.

[8]  James C Moon,et al.  Reproducibility of native T1 mapping using ShMOLLI and MOLLI - implications for sample size calculation , 2016, Journal of Cardiovascular Magnetic Resonance.

[9]  M. Robson,et al.  Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents , 2016, JACC. Cardiovascular imaging.

[10]  E. Nagel,et al.  T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.

[11]  E. Nagel,et al.  T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. , 2015, Circulation. Cardiovascular imaging.

[12]  P. Matthews,et al.  UK Biobank’s cardiovascular magnetic resonance protocol , 2015, Journal of Cardiovascular Magnetic Resonance.

[13]  P. Kellman,et al.  Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2015, Circulation.

[14]  D. Berman,et al.  Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions. , 2015, JACC. Cardiovascular imaging.

[15]  Matthew D. Robson,et al.  Systolic ShMOLLI myocardial T1-mapping for improved robustness to partial-volume effects and applications in tachyarrhythmias , 2015, Journal of Cardiovascular Magnetic Resonance.

[16]  N. Geller,et al.  Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. , 2015, American heart journal.

[17]  N. Sattar,et al.  Pathophysiology of LV Remodeling in Survivors of STEMI , 2015, JACC Cardiovascular Imaging.

[18]  S. K. White,et al.  Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload , 2015, Journal of magnetic resonance imaging : JMRI.

[19]  C. Kramer.  Role of Cardiac MR Imaging in Cardiomyopathies , 2015, The Journal of Nuclear Medicine.

[20]  P. Kellman,et al.  Characterization of myocardial T1-mapping bias caused by intramyocardial fat in inversion recovery and saturation recovery techniques , 2015, Journal of Cardiovascular Magnetic Resonance.

[21]  M. Robson,et al.  Inversion time calculations have varying impact on short, intermediate and long MOLLI T1 values: implications for studies using T1-mapping sequences , 2015, Journal of Cardiovascular Magnetic Resonance.

[22]  M. Robson,et al.  Adenosine stress native T1 mapping detects microvascular disease in diabetic cardiomyopathy, without the need for gadolinium-based contrast , 2015, Journal of Cardiovascular Magnetic Resonance.

[23]  S. Piechnik,et al.  T1 mapping and survival in systemic light-chain amyloidosis , 2014, European heart journal.

[24]  M. Mayr,et al.  Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. , 2015, JACC. Cardiovascular imaging.

[25]  S. Furui,et al.  Brain gadolinium deposition after administration of gadolinium-based contrast agents , 2015, Japanese Journal of Radiology.

[26]  S. K. White,et al.  Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance , 2014, Journal of Cardiovascular Magnetic Resonance.

[27]  J. Francis,et al.  Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values , 2014, Journal of Cardiovascular Magnetic Resonance.

[28]  E. Nagel,et al.  Aortic Stiffness and Interstitial Myocardial Fibrosis by Native T1 Are Independently Associated With Left Ventricular Remodeling in Patients With Dilated Cardiomyopathy , 2014, Hypertension.

[29]  B. Prendergast,et al.  121 High Diagnostic Yield in Patients Presenting with Acute Chest Pain, Positive Troponins but non-obstructive Coronaries by Cardiovascular Magnetic Resonance imaging with Conventional and Novel T1 Mapping Techniques , 2014, Heart.

[30]  M. Robson,et al.  Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.

[31]  S. K. White,et al.  Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.

[32]  S. Piechnik,et al.  Acute chest pain and massive LV hypertrophy in a 38-year-old man , 2013, Heart.

[33]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[34]  Stefan Neubauer,et al.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.

[35]  Chia-Ying Liu,et al.  Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). , 2013, Journal of the American College of Cardiology.

[36]  M. Robson,et al.  Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction. , 2013, JACC. Cardiovascular imaging.

[37]  P. Matthews,et al.  Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches , 2013, Journal of Cardiovascular Magnetic Resonance.

[38]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[39]  Reza Razavi,et al.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.

[40]  E. Nagel,et al.  Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.

[41]  S. K. White,et al.  Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease , 2013, Journal of Cardiovascular Magnetic Resonance.

[42]  Andrew S Flett,et al.  Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.

[43]  S. K. White,et al.  Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI , 2013, Journal of Cardiovascular Magnetic Resonance.

[44]  S. Neubauer,et al.  Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis , 2013, Heart Failure Reviews.

[45]  D. Bluemke,et al.  Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials , 2012, Journal of Cardiovascular Magnetic Resonance.

[46]  Andrew S Flett,et al.  Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR , 2012, Journal of Cardiovascular Magnetic Resonance.

[47]  Stefan Neubauer,et al.  Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.

[48]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[49]  M. Robson,et al.  Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction , 2012, Journal of Cardiovascular Magnetic Resonance.

[50]  S. Xirasagar,et al.  Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease , 2012, Clinical kidney journal.

[51]  F. Sardanelli,et al.  Cardiac magnetic resonance: impact on diagnosis and management of patients with congenital cardiovascular disease. , 2011, Clinical radiology.

[52]  Pierre Croisille,et al.  Assessment of myocardial fibrosis with cardiovascular magnetic resonance. , 2011, Journal of the American College of Cardiology.

[53]  Stefan Neubauer,et al.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[54]  Sandeep N. Gupta,et al.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.

[55]  R. Kim,et al.  Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. , 2008, JACC. Cardiovascular imaging.

[56]  O. Simonetti,et al.  Rapid phase-modulated water excitation steady-state free precession for fat suppressed cine cardiovascular MR , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[57]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[58]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[59]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[60]  David Machin,et al.  Sample Size Tables for Clinical Studies , 1997 .

[61]  E. Nagel,et al.  Mapping in Discrimination of Hypertrophic Phenotypes : Hypertensive Heart Disease and Hypertrophic Cardiomyopathy Findings From the International T 1 Multicenter Cardiovascular Magnetic Resonance Study , 2022 .